The claudin 18.2 IHC kit is intended to detect claudin 18.2 protein in formalin-fixed, paraffin-embedded (FFPE) tissue sections in vitro by IHC and to assist in the identification of malignant tumor patients who benefit from the treatment with target

Abnormally high expression of programmed death-ligand 1 (PD-L1) on tumor cells and antigen-presenting cells in the tumor microenvironment mediates tumor immune escape, since PD-L1 binding to its receptor, programmed death-1 (PD1) on the surface of T

B cell receptor (BCR) sequencing panel is used to detect the rearrangement of human B lymphocyte receptor gene in relative quantitation. The results of this assay mainly assist the diagnosis of ALL, MM and CLL by detecting BCR gene rearrangement, so

The BCR-ABL fusion gene detection kit is a quantitative BCR-ABL1 p210 assay using quantitative PCR (qPCR）.

Myeloproliferative-Neoplasms（MPN）is a group of clonal hematopoietic stem cell diseases characterized by the continuous proliferation of one or more myeloid lineages in the bone marrow. The WHO 2016 classification of MPN includes seven sub-types, am

The c-MET exon 14 skipping mutation exists in a variety of solid tumors, mainly in non-small cell lung cancer (NSCLC). The mutation rate in lung adenocarcinoma is about 3%, and the mutation rate in lung squamous cell carcinoma is about 2%, especially

This kit uses PCR+CE methods to detect nine mononucleotide repeat sites including BAT25, BAT26, NR21, NR24, MONO27, BAT52, BAT56, BAT59, and BAT60 in tumor tissues to guide the diagnosis of colorectal cancer patients, especially treated with immune c

Mismatch Repair (MMR) occurs in the process of DNA replication, recombination and damage repair, and can recognize and repair erroneous insertions, deletions and integrations. Four common mismatch repair proteins in the human body, namely hMLH1, hMSH